Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CACI International Inc filings document the formal disclosures of an operating national security technology company serving U.S. government defense, intelligence and federal civilian customers. Recent Form 8-K reports cover fiscal-quarter results, financial-condition disclosures, material agreements and exhibits tied to the company's operating performance and contract-driven business.
The filing record also documents capital-structure actions, including unsecured senior notes due 2033, related subsidiary guarantees and financing arrangements connected to the completed ARKA Group acquisition. Other disclosures address accounts receivable purchase arrangements, board composition, director independence, compensatory arrangements and other governance matters reported under current-report requirements.
CACI International Inc. director reports stock sale
A director of CACI International Inc. (CACI), William L. Jews, reported selling 3,000 shares of CACI common stock on 12/10/2025. The sale was reported at a price of $585.82 per share. After this transaction, he beneficially owns 3,384 CACI common shares in direct ownership. The filing is a standard Form 4 insider transaction report and does not include any derivative securities activity.
CACI has a security holder filing a notice of intent to sell 3,000 shares of common stock through broker Merrill at an aggregate market value of 1755225.46, with the sale expected on 12/10/2025 on the NYSE. Shares outstanding were 22,079,710, providing context for the size of the planned sale.
The shares planned for sale were originally acquired from CACI as stock compensation in multiple grants between 2015 and 2018, with individual awards ranging from 268 to 351 shares that together total 3,000 shares. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about CACI’s current or prospective operations.
CACI International Inc entered into a Second Amended and Restated Credit Agreement on November 25, 2025, replacing its prior 2021 facility. The agreement provides a $1.25 billion term loan facility and a $2.0 billion revolving credit facility, each maturing on November 25, 2030, with a $150.0 million swing line subfacility and a $25.0 million letter of credit subfacility. The company may add incremental debt within a detailed leverage- and coverage-based framework, including amounts tied to Consolidated EBITDA and specified leverage ratio thresholds. Obligations are secured by substantially all assets of CACI and its material domestic subsidiaries and are guaranteed by those subsidiaries, subject to customary exceptions. Interest on borrowings is based on a base rate or Term SOFR plus a margin set by the company’s Consolidated Total Net Leverage Ratio, and the agreement includes financial covenants on leverage and interest coverage, along with customary limitations on additional debt, liens, investments, asset transfers, dividends and certain transactions.
Morgan Stanley and Atlanta Capital Management Company, LLC filed Amendment No. 7 to Schedule 13G reporting beneficial ownership in CACI International Inc. as of 09/30/2025.
Morgan Stanley reported 1,551,022 shares beneficially owned, representing 7.1% of the common stock, with shared voting power 1,406,590 and shared dispositive power 1,494,434. Atlanta Capital reported 1,313,754 shares beneficially owned, representing 6.0%, with shared voting power 1,194,448 and shared dispositive power 1,261,289.
Both filers certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
CACI International (CACI) Chief Financial Officer Jeffrey D. MacLauchlan reported equity award vesting and related tax withholdings on 11/01/2025. He acquired 1,101 shares upon vesting of restricted stock units and 5,072 shares upon vesting of performance RSUs (both shown with code M). To cover taxes, the issuer withheld 541 shares and 2,488 shares at $562.25 per share (code F). Following these transactions, his directly held stake was 7,475 shares.
Footnotes state the RSUs were granted on November 1, 2022 and vest one-third per year over three years, while the PRSUs vested on the third anniversary based on a three‑year performance measure.
CACI International Inc reported first‑quarter results for the period ended September 30, 2025. Revenue was $2,287.6 million, up 11.2% year over year, driven by organic growth and program wins. Income from operations rose to $212.3 million (up 18%). Diluted EPS was $5.63 versus $5.33 a year ago, with net income of $124.8 million.
Operating cash flow strengthened to $171.1 million versus $34.7 million last year, aided by working capital. The company ended the quarter with cash of $133.0 million and long‑term debt (net of current portion) of $2,708.7 million. CACI has interest rate swaps covering $900.0 million of floating‑rate debt. As of October 17, 2025, common shares outstanding were 22,079,710.
Backlog reached $33.9 billion, and remaining performance obligations were $13.1 billion, with approximately 44% and 63% expected to convert to revenue over the next 12 and 24 months, respectively. Revenue mix included $1,300.7 million from Technology and $986.9 million from Expertise; Department of Defense revenue was $1,179.6 million. The company recorded no goodwill impairments. In legal matters, a jury entered a $42 million judgment in November 2024; CACI has appealed and recorded no amounts related to this case.
CACI International Inc filed an 8-K noting it has released financial results for its first quarter of fiscal year 2026. The company furnished a press release as Exhibit 99.1 and provided the schedule for a conference call and webcast on October 23, 2025.
The filing is administrative, serving to make the results announcement and call details publicly available. CACI’s common stock trades on the NYSE under the symbol CACI.
CACI International Inc reported the final results of its Annual Meeting held on October 16, 2025 and confirmed shareholder approval of the Company’s 2025 Incentive Compensation Plan. With the 2025 Plan effective, no further awards will be granted under the 2016 Amended and Restated Incentive Compensation Plan.
Shareholders elected ten directors. They also approved, on an advisory basis, executive compensation with 17,611,682 votes for, 965,909 against, and 34,249 abstentions. The 2025 Incentive Compensation Plan was approved with 17,750,993 votes for, 833,817 against, and 27,030 abstentions. Shareholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 with 19,629,748 votes for, 568,027 against, and 15,369 abstentions.
The 2025 Plan’s full text was filed as Exhibit 10.1 and is incorporated by reference.
CACI International (CACI) filed a Form 4 reporting that director Scott Morrison received a grant of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs vest in four tranches during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following the reported transaction, 338 derivative securities were beneficially owned on a direct basis. This filing reflects routine director equity compensation and a defined vesting schedule.
CACI International Inc. (CACI) — Form 4 insider activity: Officer Eric Blazer (SVP, Corp. Controller & CAO) reported equity transactions on 10/16/2025. He acquired 98 shares of CACI common stock via the conversion of previously granted restricted stock units (Transaction Code M). To cover taxes, 30 shares were disposed at $518.23 (Code F).
Following these transactions, Blazer directly beneficially owned 180 shares. The filing also shows 99 restricted stock units remaining beneficially owned after the reported activity. The RSUs were originally granted on October 16, 2023 and vest in three equal annual installments.